Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001144204-16-124460

President and CEO acquired 110,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GILL JOHN · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-15 Exercise or conversion : show line 1 in the form +20,000 $1.60 $32,000 632,244 D
2016-09-15 Exercise or conversion : show line 2 in the form +20,000 $1.45 $29,000 652,244 D
2016-09-15 Exercise or conversion : show line 3 in the form +20,000 $1.64 $32,800 672,244 D
2016-09-15 Exercise or conversion : show line 4 in the form +20,000 $1.51 $30,200 692,244 D
2016-09-16 Exercise or conversion : show line 5 in the form +10,000 $2.59 $25,900 702,244 D
2016-09-16 Exercise or conversion : show line 6 in the form +20,000 $2.47 $49,400 722,244 D

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2016-09-15 Exercise or conversion : show line 7 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-16 Exercise or conversion : show line 11 in the form Employee Stock Option (right to buy) −10,000 0 D
2016-09-16 Exercise or conversion : show line 12 in the form Employee Stock Option (right to buy) −20,000 0 D
Loading xslF345X03/v449040_4.xml…